Author: healthadmin

Get the latest news in health technology, digital health and health AI with this weekly overview. News for the week from June 1st to June 5th. President Trump signs AI Cybersecurity Executive Order President Donald Trump signed an executive order Tuesday aimed at strengthening AI-enabled cybersecurity for government systems. This order puts in place a framework for voluntary testing of frontier artificial intelligence models with advanced cyber capabilities. The order requires AI companies to voluntarily participate in a benchmarking process to assess a model’s “advanced cyber capabilities” and determine whether it should be considered a “covered frontier model.” The order,…

Currently, more than a quarter of people with type 2 diabetes use GLP-1 receptor agonists, a class of medications that includes Ozempic. But a new study by Stanford Medicine and international collaborators suggests that these widely prescribed drugs may be less effective for some patients because of genetics. The study found that about 10% of people carry a genetic variation associated with a phenomenon known as GLP-1 resistance. People with these mutations appear to produce higher levels of the hormone GLP-1 (glucagon-like peptide 1), which helps regulate blood sugar levels, but this hormone does not seem to work as effectively…

Octopuses have long been known for their amazing intelligence. A famous example is Inky the octopus, which escaped from the New Zealand National Aquarium in 2016 by slipping through a drainpipe and returning to the ocean. Now, researchers at Dartmouth College have discovered another surprising ability. New research published in current biology Octopuses have learned how to use mirrors to find hidden food out of direct view, showing advanced spatial thinking, researchers discovered. “Our findings are the first to show that invertebrates can use mirrors to understand their environment and locate prey,” says lead author Mary Kieserer (Guarini ’25). He…

A recent study published as a preprint on the academic platform SSRN.com suggests that a person’s political ideology predicts their preferences in the global sports competition between soccer stars Lionel Messi and Cristiano Ronaldo. This study provides evidence that political identity shapes cultural preferences far beyond the realm of government, with liberal-leaning individuals preferring Messi and conservative-leaning individuals preferring Ronaldo. This link between politics and sports preferences tends to be strongest among younger generations who grew up in highly politically polarized environments. In recent years, political scientists have studied a concept known as identity categorization. This explains how a single…

A new universal coronavirus vaccine has passed its first human clinical trial, an important step towards widespread protection against future virus outbreaks. An experimental vaccine developed by Cambridge University researchers and university spin-out company DIOSynVax (DVX) Ltd was found to be safe and cause no serious side effects in a study of 39 healthy volunteers. Unlike traditional vaccines that target specific virus strains, this vaccine is designed to protect against multiple members of the sarbecocoronavirus family. This group includes SARS-CoV-2, the virus that causes the COVID-19 pandemic, as well as SARS and several related bat coronaviruses that could potentially infect…

A series of major studies have shown that finerenone preserves kidney function, reduces cardiovascular risk, and improves survival in a much wider range of chronic kidney disease (CKD) patients than currently recommended. These benefits extend beyond diabetes to nondiabetic CKD and glomerular disease. The results of this study were presented today at the European Society of Nephrology Conference in Glasgow, UK, and simultaneously published in three of the world’s leading medical journals. Lancet, New England Medical Journal and Japan Automobile Manufacturers Association – A rare achievement in clinical research. Finerenone is a nonsteroidal mineralocorticoid receptor antagonist currently approved for the…

Regional health system WellSpan Health has entered into a seven-year strategic partnership with Philips to advance advanced imaging technology and co-develop new AI and technology tools across its network. Philips technology supports WelSpan’s entire network of 12 hospitals, diagnostic imaging centers, and ambulatory surgery centers across central Pennsylvania and northern Maryland. The long-term commercial agreement establishes Philips as WellSpan’s preferred vendor across patient monitoring, enterprise informatics, and all applicable imaging modalities, including CT, MR, digital X-ray, ultrasound, and image-guided therapy. The commercial agreement includes a structured approach to technology lifecycle management, with the organizations saying Welspun and Philips will coordinate…

Malignant tumors remain a major threat to human health, and conventional treatments and first-generation immune checkpoint inhibitors (ICIs) face limitations such as drug resistance and low response rates. The comprehensive review is now available online on September 22, 2025 and was published in the journal Volume 9, Issue 1. Pancreatology Journal March 30, 2026 T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domains (TIGITs) are highlighted as promising second-generation targets to address these challenges. Unlike LAG-3, TIM-3, and other emerging checkpoints, TIGIT is widely expressed on T cells, natural killer (NK) cells, and regulatory T cells (Tregs), and primarily binds competitively…

In 2025, the European Medicines Agency approved two antibodies for Alzheimer’s disease: lecanemab (LeqembiTM, manufactured by Biogen) and donanemab (KisunlaTM, manufactured by Eli Lilly and Company). Both of these are based on immunotherapy (the use of molecules of the immune system to treat disease). These lab-derived antibodies work against Aβ peptide, a protein fragment that accumulates in the brains of Alzheimer’s patients. The fact that the immune system eliminates this protein helps slow the cognitive decline characteristic of this disease. These two antibodies are the first disease-modifying therapies for Alzheimer’s disease. They can stop this devastating condition and in some…

Sleep apnea is significantly more severe on weekends than on weekdays, and the effects are even greater in people who sleep less or shift their sleep schedules on weekends, according to a new study published in . American Journal of Respiratory and Critical Care Medicine. Obstructive sleep apnea (OSA) is a common but serious sleep disorder in which your airway repeatedly collapses during sleep, causing you to stop breathing repeatedly throughout the night. The severity of OSA is usually measured by counting how many times per hour a person’s breathing stops or is severely restricted. This number is known as…